https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies

Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies

The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital role of pharmacists in implementing emerging therapies and optimizing cardiovascular risk reduction.

administrator

Related Articles